Entities Organizations Interius BioTherapeutics
Organization · Biotech
Last updated 2026-04-10
ConfirmedInterius BioTherapeutics
Interius BioTherapeutics is a clinical-stage biotechnology company engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases in oncology, autoimmunity, and beyond. The company's proprietary LENTIVECTOR platform enables in vivo generation of CAR T and CAR NK cells through a single intravenous infusion, offering a potential off-the-shelf, scalable alternative to traditional ex vivo cell therapies.
Not to be confused with similarly named companies; this entity is a biotechnology firm focused on in vivo cell and gene therapy. Acquired by Kite, a Gilead Company.
Same as
Extended Facts
Relationships
People
Products
Identity Triangulation
Cross-platform entity consensus: 2 independent sources
SameAs links connect this entity to its canonical presence across authoritative platforms.
Schema Record
The Schema.org JSON-LD record for this entity. Available via the open API at the endpoint below.
{
"@context": "https://schema.org",
"@type": "Organization",
"name": "Interius BioTherapeutics",
"url": "https://interiusbio.com/",
"description": "Interius BioTherapeutics is a clinical-stage biotechnology company engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases in oncology, autoimmunity, and beyond. The company's proprietary LENTIVECTOR platform enables in vivo generation of CAR T and CAR NK cells through a single intravenous infusion, offering a potential off-the-shelf, scalable alternative to traditional ex vivo cell therapies.",
"disambiguatingDescription": "Not to be confused with similarly named companies; this entity is a biotechnology firm focused on in vivo cell and gene therapy. Acquired by Kite, a Gilead Company.",
"sameAs": [
"https://www.gilead.com/news/news-details/2025/kite-to-acquire-interius-biotherapeutics-to-advance-in-vivo-platform",
"https://www.linkedin.com/company/interius-biotherapeutics"
],
"identifier": [
{
"@type": "PropertyValue",
"name": "Website",
"value": "https://www.gilead.com/news/news-details/2025/kite-to-acquire-interius-biotherapeutics-to-advance-in-vivo-platform",
"url": "https://www.gilead.com/news/news-details/2025/kite-to-acquire-interius-biotherapeutics-to-advance-in-vivo-platform"
},
{
"@type": "PropertyValue",
"name": "Linkedin",
"value": "https://www.linkedin.com/company/interius-biotherapeutics",
"url": "https://www.linkedin.com/company/interius-biotherapeutics"
}
],
"dateModified": "2026-04-10T13:08:57.039",
"legalName": "Interius BioTherapeutics, Inc.",
"logo": {
"@type": "ImageObject",
"url": "https://interiusbio.com/wp-content/uploads/2023/10/Interius_Logo_Final_RGB.png"
},
"foundingDate": "2019-01-01T00:00:00",
"address": {
"@type": "PostalAddress",
"streetAddress": "3401 Grays Ferry Ave, Building 200, Suite 300",
"addressLocality": "Philadelphia",
"addressRegion": "PA",
"postalCode": "19146",
"addressCountry": "US"
},
"slogan": "Making genetic medicine a reality for everybody",
"contactPoint": {
"@type": "ContactPoint",
"email": "info@interiusbio.com",
"contactType": "general"
},
"knowsAbout": [
{
"@type": "Thing",
"name": "in vivo CAR-T therapy",
"url": "https://interiusbio.com/pipeline/"
},
{
"@type": "Thing",
"name": "lentiviral vectors",
"url": "https://interiusbio.com/platform/"
},
{
"@type": "Thing",
"name": "genetic medicine delivery",
"url": "https://interiusbio.com/platform/"
},
{
"@type": "Thing",
"name": "cell and gene therapy",
"url": "https://interiusbio.com/pipeline/"
},
{
"@type": "Thing",
"name": "oncology therapeutics",
"url": "https://interiusbio.com/pipeline/"
},
{
"@type": "Thing",
"name": "autoimmune disease treatment",
"url": "https://interiusbio.com/pipeline/"
},
{
"@type": "Thing",
"name": "off-the-shelf cell therapy",
"url": "https://interiusbio.com/pipeline/"
},
{
"@type": "Thing",
"name": "precision medicine",
"url": "https://interiusbio.com/platform/"
}
],
"hasOfferCatalog": [
{
"@type": "OfferCatalog",
"name": "Therapeutic Pipeline",
"itemListElement": [
{
"@type": "Offer",
"itemOffered": {
"@type": "Service",
"name": "INT2104 for B-cell malignancies",
"url": "https://interiusbio.com/pipeline/#INT2104"
}
},
{
"@type": "Offer",
"itemOffered": {
"@type": "Service",
"name": "INT2106 for autoimmune diseases",
"url": "https://interiusbio.com/pipeline/#INT2106"
}
}
]
}
]
}